Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 3

1(20.0%)

5Total

N/A(4)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT05452980Not ApplicableUnknown

Sleeve Gastrectomy With Reestablishment of the Acute Angle of His (SG-REACH) in Obese Patients

Role: lead

NCT04534504Not ApplicableUnknown

Sleeve Gastrectomy With Uncut Jejunal Bypass (SG-uncut JJB) Verus Sleeve Gastrectomy in Obese Patients

Role: lead

NCT04319861Not ApplicableCompleted

Anal Fistula Plug, a Retrospective Study

Role: lead

NCT04310800Not ApplicableUnknown

LIFT-plug vs LIFT, a RCT Trial

Role: lead

NCT01478139Phase 3Unknown

Ligation of Intersphincteric Fistula Tract (LIFT) Versus LIFT-plug Procedure for Anal Fistula Repair

Role: lead

NCT00951002Unknown

The Efficacy of Human Acellular Dermal Matrix in the Treatment of Anal Fistula

Role: lead

All 6 trials loaded